Jeffrey Glenn
Corporate Officer/Principal presso Stanford University School of Medicine
Patrimonio netto: 56 536 $ in data 31/03/2024
Profilo
Jeffrey S.
Glenn has a career history that includes founding positions, current jobs, and education history.
Founding Positions:- Dr. Glenn is the founder of Eiger BioPharmaceuticals, Inc., which was founded in 2008.
He held the title of Director from 2011 to 2016 and the title of Independent Director from 2008 to 2024.
Current Job(s):- Dr. Glenn is currently working at Stanford University School of Medicine, where he started in 2000.
His title is Associate Professor & Director-Hepatitis Center.
- He is also currently employed at the American Society for Clinical Investigation, with the title of Member.
Education History:- Dr. Glenn completed his undergraduate degree at the University of California, Berkeley.
-.
He obtained his doctorate degree from The University of California, San Francisco.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 20/11/2023 | 11 296 ( 0.76% ) | 56 536 $ | 31/03/2024 |
Posizioni attive di Jeffrey Glenn
| Società | Posizione | Inizio |
|---|---|---|
| Stanford University School of Medicine | Corporate Officer/Principal | 01/01/2000 |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Precedenti posizioni note di Jeffrey Glenn
| Società | Posizione | Fine |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Founder | 01/04/2024 |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Founder | 01/03/2016 |
Formazione di Jeffrey Glenn
| University of California, Berkeley | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Health Technology |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Glenn
